Development of liposomes as pharmaceutical carriers for antibiotic and gene delivery
An inhaled dry powder azithromycin liposomal formulation for the treatment of cystic fibrosis (CF) lung infection was developed based on a previously developed liposome composition by Yusuf (2014). The formulation contains liposomes composed of dimethyldioctadecylammonium bromide, soy-phosphatidylch...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2017
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.725746 |